Headlines
•AstraZeneca stock falls after FDA panel votes against new cancer drug — shares down pre-market
•UK Billionaire’s Family Office Targets More Private Equity Exits
•Globe Life declares $0.33 dividend (NYSE:GL)
•AstraZeneca stock falls after FDA panel votes against new cancer drug — shares down pre-market
•UK Billionaire’s Family Office Targets More Private Equity Exits
•Globe Life declares $0.33 dividend (NYSE:GL)
Today’s wrap
May 1, 2026 Market Wrap →
GoodMoat publishes hourly macro-headline digests synthesized by AI from leading financial newswires (Reuters, Bloomberg, Tiingo). Each bulletin is editorially reviewed for accuracy before publication. See the Macro Desk editorial process for details.